browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
b1a44552-7d1b-4e2a-8d4c-ff48a87494b2
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:16:01
Income (reported)
$40,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

THE MCMANUS GROUP

Consulting

Contact
NATE GASPAR
Phone
+1 434-989-7548
Address
zip:20001, city:Washington, state:DC, street:610 10th St. NW Suite 300
Client

ROCHE DIAGNOSTICS

Diagnostic test manufacturing

State
IN
Country
US
Effective date
2024-09-01
Issues lobbied + lobbyists (2)

MMM — Medicare/Medicaid

H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TRD — Trade (domestic/foreign)

Issues related to global trade and tariffs.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.